Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 1
2013 4
2014 1
2015 1
2017 1
2018 1
2019 2
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean pan shi yang (19 results)?
Human papillomavirus-related carcinomas of the sinonasal tract.
Bishop JA, Guo TW, Smith DF, Wang H, Ogawa T, Pai SI, Westra WH. Bishop JA, et al. Among authors: pai si. Am J Surg Pathol. 2013 Feb;37(2):185-92. doi: 10.1097/PAS.0b013e3182698673. Am J Surg Pathol. 2013. PMID: 23095507 Free PMC article.
Peripheral Circulating CD45RA-FOXP3hi T Regulatory (TReg) II Cells Provide a Window into the Activity of Intratumoral TReg Cells.
Pai SI, Marincola FM. Pai SI, et al. Trends Cancer. 2020 Jan;6(1):3-6. doi: 10.1016/j.trecan.2019.11.003. Epub 2019 Dec 3. Trends Cancer. 2020. PMID: 31952778 Free PMC article.
T(R)(eg) cells contribute to compensatory immune suppression, and therapies targeting the immunosuppressive T(R)(eg) population are being actively explored. Wang et al. characterize a subset of peripheral circulating CD45(-)FOXP3(hi) T(R)(eg) II cells that phenotypically a …
T(R)(eg) cells contribute to compensatory immune suppression, and therapies targeting the immunosuppressive T(R)(eg) population are being ac …
Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
Gleber-Netto FO, Zhao M, Trivedi S, Wang J, Jasser S, McDowell C, Kadara H, Zhang J, Wang J, William WN Jr, Lee JJ, Nguyen ML, Pai SI, Walline HM, Shin DM, Ferris RL, Carey TE, Myers JN, Pickering CR; Head and Neck Cancer Specialized Program of Research Excellence (SPORE) Human Immunodeficiency Virus (HIV) Supplement Consortium. Gleber-Netto FO, et al. Among authors: pai si. Cancer. 2018 Jan 1;124(1):84-94. doi: 10.1002/cncr.31063. Epub 2017 Oct 20. Cancer. 2018. PMID: 29053175 Free PMC article.
SUPREME-HN: a retrospective biomarker study assessing the prognostic value of PD-L1 expression in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Pai SI, Cohen EEW, Lin D, Fountzilas G, Kim ES, Mehlhorn H, Baste N, Clayburgh D, Lipworth L, Resteghini C, Shara N, Fujii T, Zhang J, Stokes M, Wang H, Twumasi-Ankrah P, Wildsmith S, Khaliq A, Melillo G, Shire N. Pai SI, et al. J Transl Med. 2019 Dec 26;17(1):429. doi: 10.1186/s12967-019-02182-1. J Transl Med. 2019. PMID: 31878938 Free PMC article.
Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma.
Lyford-Pike S, Peng S, Young GD, Taube JM, Westra WH, Akpeng B, Bruno TC, Richmon JD, Wang H, Bishop JA, Chen L, Drake CG, Topalian SL, Pardoll DM, Pai SI. Lyford-Pike S, et al. Among authors: pai si. Cancer Res. 2013 Mar 15;73(6):1733-41. doi: 10.1158/0008-5472.CAN-12-2384. Epub 2013 Jan 3. Cancer Res. 2013. PMID: 23288508 Free PMC article.